ArticleNMR in biomedicine2025
Double-Step R1rho-Based Lorentzian Fitting (DROF): A New CEST Analysis Approach and Its Comparison With Existing Methods.
Article in NMR in biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multi-Contrast Human Brain CEST MRI at 11.7 T: First In Vivo Demonstration.Magnetic resonance in medicine · 2026Article
- Characterizing Metabolic and Compositional Heterogeneity of Calf Muscle Using CEST MRI at 3 T.NMR in biomedicine · 2026Article
- Limited Contribution of TMolecular imaging and biology · 2026Article
- Double-Step R1rho-Based Lorentzian Fitting (DROF): A New CEST Analysis Approach and Its Comparison With Existing Methods.NMR in biomedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
At 3-T MRI, reliable quantification of CEST contrast is challenged by peak overlap and broad background contamination. Because of this limitation, some previous studies employ four-pool Lorentzian fitting (i.e., amide, direct water saturation, magnetization transfer, and relayed nuclear Overhauser enhancement) for CEST analysis at 3 T, where the multiple CEST contrasts at positive frequency offsets are treated as a single pool. In addition, for fitting-based methods, the fitting accuracy can be readily affected by initial values and boundary conditions. To address these problems, a new CEST analysis approach, named double-step R1rho-based Lorentzian fitting (DROF), with initial value randomization, was developed in this study for extracting five-pool (additional CEST@2 ppm pool) Lorentzian fitting parameters at 3 T. Moreover, a comprehensive evaluation framework including three metrics was proposed to assess the performance of CEST analysis methods. The accuracy and robustness of DROF were evaluated using both simulation and in vivo human data at 3 T, and its performance was compared with existing methods. Results demonstrate that DROF offers improved specificity and stability, suggesting its potential to enhance CEST applicability at 3 T.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.